...
首页> 外文期刊>acs omega >Synthesis and In Vitro Evaluation of 2-3-(2-Aminoethyl)-1H-indol-1-yl-N-benzylquinazolin-4-amine as a Novel p97/VCP Inhibitor Lead Capable of Inducing Apoptosis in Cancer Cells
【24h】

Synthesis and In Vitro Evaluation of 2-3-(2-Aminoethyl)-1H-indol-1-yl-N-benzylquinazolin-4-amine as a Novel p97/VCP Inhibitor Lead Capable of Inducing Apoptosis in Cancer Cells

机译:2-3-(2-氨基乙基)-1H-吲哚-1-基-N-苄基喹唑啉-4-胺作为诱导癌细胞凋亡的新型p97/VCP抑制剂先导物的合成及体外评价

获取原文
获取原文并翻译 | 示例

摘要

P97/VCP, an endoplasmic reticulum associated protein, belongs to AAA ATPase family, ubiquitous ATPases associated with various cellular activities. Recent research has elucidated the roles of p97/VCP and evaluated its potential as a therapeutic target for some kinds of cancer diseases. We screened the small molecule compounds from a previously established library and found promise in the compound 2-3-(2-aminoethyl)-1H -indol-1-yl-N -benzylquinazolin-4-amine (FQ393). Data from docking simulation indicates FQ393 acts as an ATP competitor, and ATPase activity assays showed FQ393 was an inhibitor of p97/VCP. Furthermore, in vitro FQ393 is able to promote apoptosis and prohibit proliferation in a variety of cancer cell lines. Using comparative proteomic profiling of HCT-116 cells, we found significantly different canonical KEGG pathways, which revealed that the protein changes in FQ393 groups were associated with p97/VCP or tumor-related pathways. The present data suggests that FQ393 exerts antitumor activity, at least in part through p97/VCP inhibition.
机译:P97/VCP 是一种内质网相关蛋白,属于 AAA ATP 酶家族,是与各种细胞活动相关的普遍存在的 ATP 酶。最近的研究阐明了p97 / VCP的作用,并评估了其作为某些癌症疾病治疗靶点的潜力。我们从先前建立的库中筛选了小分子化合物,并在化合物2-[3-(2-氨基乙基)-1H-吲哚-1-基]-N-苄基喹唑啉-4-胺(FQ393)中发现了前景。对接模拟数据表明 FQ393 是 ATP 竞争者,ATP 酶活性测定表明 FQ393 是 p97/VCP 的抑制剂。此外,体外FQ393能够促进细胞凋亡并抑制多种癌细胞系的增殖。通过对HCT-116细胞的蛋白质组学比较分析,我们发现了显著不同的经典KEGG通路,这表明FQ393组的蛋白质变化与p97/VCP或肿瘤相关通路有关。目前的数据表明,FQ393 至少部分通过抑制 p97/VCP 发挥抗肿瘤活性。

著录项

  • 来源
    《acs omega》 |2020年第49期|31784-31791|共8页
  • 作者单位

    School of Pharmaceutical Sciences, Capital Medical University;

    Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Capital Medical University;

    Department of Biomaterials, Beijing Laboratory of Biomedical Materials and Key Laboratory of Biomedical Materials of Natural Macromolecules, Beijing University of Chemical Technology;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号